NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Priority Review Voucher Reauthorization. Newborn Screening.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
| ALLISON HERRITY | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Prescription Drug User Fee Act (PDUFA) Reauthorization. PRV Reauthorization. Promising Pathways Act 2.0. Public Law 119-21: One Big Beautiful Bill Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| VICTORIA GEMME | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. FDA Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA GEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.